Systemtherapie des kolorektalen Karzinoms
Authors:
- 1 June 2005
- journal article
- research article
- Published by Springer Nature in Der Chirurg
- Vol. 76 (6) , 570-574
Abstract
Die medikamentöse Behandlung des kolorektalen Karzinoms hat in den letzten 10 Jahren eindrückliche Fortschritte gemacht. Neben dem altbewährten 5-Fluorouracil stehen heute neue Zytostatika zur Verfügung wie Irinotecan und Oxaliplatin. Monoklonale Antikörper wie Bevacizumab und Cetuximab haben erfolgreich Eingang in aktuelle Therapiestrategien gefunden. Auf der Basis randomisierter klinischer Studien lassen sich heute rationale Therapiestrategien formulieren, wie in diesem Beitrag dargestellt.Keywords
This publication has 14 references indexed in Scilit:
- Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal CancerNew England Journal of Medicine, 2004
- Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine, 2004
- Survival of Patients With Advanced Colorectal Cancer Improves With the Availability of Fluorouracil-Leucovorin, Irinotecan, and Oxaliplatin in the Course of TreatmentJournal of Clinical Oncology, 2004
- Phase III Randomized Trial of Docetaxel Plus Cisplatin Versus Vindesine Plus Cisplatin in Patients With Stage IV Non-Small-Cell Lung Cancer: The Japanese Taxotere Lung Cancer Study GroupJournal of Clinical Oncology, 2004
- FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR StudyJournal of Clinical Oncology, 2004
- A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal CancerJournal of Clinical Oncology, 2004
- Scheduling of Fluorouracil: A Forget-Me-Not in the Jungle of DoubletsJournal of Clinical Oncology, 2004
- Oral Capecitabine Compared With Intravenous Fluorouracil Plus Leucovorin in Patients With Metastatic Colorectal Cancer: Results of a Large Phase III StudyJournal of Clinical Oncology, 2001
- Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III StudyJournal of Clinical Oncology, 2001
- Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine, 2000